Forward and Swap Contracts (Tables)
|
12 Months Ended |
Mar. 31, 2020 |
|---|
| Notes To Financial Statements [Abstract] |
|
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value |
| | | | | | | | | | | | | | | | | | | | Asset Derivatives | | Liability Derivatives | | | Fair Value at | | Fair Value at | | Fair Value at | | Fair Value at | Balance Sheet Location | | March 31, 2020 | | March 31, 2019 | | March 31, 2020 | | March 31, 2019 | Prepaid & Other | | $ | 124 |
| | $ | 552 |
| | $ | — |
| | $ | — |
| Accrued expenses and other | | $ | — |
| | $ | — |
| | $ | 912 |
| | $ | 278 |
|
|
| Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance |
The following table presents the impact of derivative instruments and their location within the Consolidated Statements of Income: | | | | | | | | | | | | | | | | | | Location of (loss) gain recognized in income | | Amount of (loss) gain recognized in income | Years Ended March 31, | 2020 | | 2019 | | 2018 | Foreign currency forward contracts | | Selling, general and administrative | | $ | 798 |
| | $ | 235 |
| | $ | (1,357 | ) | Commodity swap contracts | | Cost of revenues | | $ | (660 | ) | | $ | 434 |
| | $ | 373 |
|
|